Literature DB >> 1358985

Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time.

H Farzadegan1, J S Chmiel, N Odaka, L Ward, L Poggensee, A Saah, J P Phair.   

Abstract

Serum antibody to p24 (anti-p24) and p24 antigen, alone and in combination with CD4+ lymphocyte number, were evaluated as predictors of progression of human immunodeficiency virus type 1 (HIV-1) infection. Two hundred six HIV-1-prevalent seropositive men in the Multi-center AIDS Cohort Study since 1984-1985 were studied cross-sectionally and 84 seroconverters were evaluated longitudinally. Cross-sectional analyses revealed significant associations among titer of anti-p24, CD4+ cell count, disease status (Centers for Disease Control class), and progression to AIDS. A high titer of anti-p24 was associated with lack of p24 antigenemia. Longitudinal studies of seroconverters demonstrated that a low titer of anti-p24, low CD4+ cell count, and detection of HIV-1 p24 antigen are individually strong predictors of AIDS, but only low CD4+ cell count retains its independent predictive value in multivariate analysis of the three markers during the period immediately after infection with HIV-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358985     DOI: 10.1093/infdis/166.6.1217

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Primary infection by type 1 human immunodeficiency virus: diagnosis and prognosis.

Authors:  P Vanhems; R Beaulieu
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

2.  The relationship between antibody to R7V and progression of HIV type 1 infection.

Authors:  Joseph B Margolick; Jean M Da Costa Castro; Albert Sanchez; Francois Gemrot; John P Phair; Beth D Jamieson; Charles R Rinaldo; Lisa P Jacobson
Journal:  AIDS Res Hum Retroviruses       Date:  2010-04       Impact factor: 2.205

3.  In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.

Authors:  S Rusconi; A Riva; L Meroni; G Zehender; F Cocchi; L Scapellato; M Galli
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 4.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

5.  Biomarkers predicting progression of human immunodeficiency virus-related disease.

Authors:  Amar Kanekar
Journal:  J Clin Med Res       Date:  2010-03-11

Review 6.  Isotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.

Authors:  Martyn A French; Laila N Abudulai; Sonia Fernandez
Journal:  Vaccines (Basel)       Date:  2013-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.